Navigating the Thrombus Burden: Is Deferred Stenting the Answer to the No-Reflow Dilemma?
Pakistan Heart Journal · 30.06.2026 · 59 (3) · 673-675
DOI: 10.47144/phj.v59i3.3803 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pakistan Heart Journal, online erschienen am 30.06.2026. Verfasst von Saadia Abubakar. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Primary percutaneous coronary intervention (PCI) remains the gold-standard reperfusion strategy for patients presenting with acute ST-segment elevation myocardial infarction (STEMI) [1]. The therapeutic goal is straightforward yet time-critical: rapid restoration of coronary blood flow to salvage jeopardized myocardium and preserve ventricular function. Despite substantial advances in contemporary interventional cardiology, one of the most challenging obstacles encountered during primary PCI is the presence of a large intracoronary thrombus burden. Heavy thrombotic burden is frequently observed in STEMI and represents a major predictor of distal embolization, microvascular obstruction, and impaired myocardial reperfusion following intervention [2]. Even when successful epicardial coronary patency is achieved, embolization of thrombotic debris into the distal microcirculation can precipitate the dreaded no-reflow or slow-reflow phenomenon, resulting in persistent myocardial ischemia despite angiographically successful PCI [3]. Because no-reflow is strongly associated with larger infarct size, adverse ventricular remodeling, heart failure, and increased mortality, strategies aimed at preventing microvascular injury remain a critical area of investigation. In this context, deferred stenting has emerged as an appealing therapeutic approach [4]. Rather than immediate stent implantation, the strategy involves restoring initial coronary flow through thrombectomy, balloon angioplasty, or pharmacologic therapy, followed by a planned delay in stent deployment for 24–72 hours while intensive antithrombotic treatment facilitates thrombus resolution. The theoretical advantage is compelling: allowing time for thrombus burden to diminish may reduce distal embolization, improve microvascular perfusion, and ultimately enhance clinical outcomes. However, enthusiasm for routine adoption has been tempered by randomized evidence, most notably the DANAMI-3-DEFER trial, which failed to demonstrate a significant benefit of deferred stenting in an unselected STEMI population [5]. Consequently, the role of deferred stenting remains a subject of ongoing debate. In this issue of the Pakistan Heart Journal, Khan et al. contribute important real-world evidence from a high-volume tertiary care center in Pakistan [6]. In their retrospective observational cohort study of 450 STEMI patients with significant thrombus burden (TIMI thrombus grade ≥3), the investigators compared outcomes between immediate stenting (n=218) and deferred stenting (n=232). The findings are noteworthy. Deferred stenting was associated with a dramatic reduction in the incidence of no-reflow/slow-reflow compared with immediate stenting (5.2% vs. 28.9%, p
Zitieren
APA
Abubakar, S. (2026). Navigating the Thrombus Burden: Is Deferred Stenting the Answer to the No-Reflow Dilemma?. Pakistan Heart Journal, 59(3), 673-675. https://doi.org/10.47144/phj.v59i3.3803
Vancouver
Abubakar S. Navigating the Thrombus Burden: Is Deferred Stenting the Answer to the No-Reflow Dilemma?. Pakistan Heart Journal. 2026;59(3):673-675. doi:10.47144/phj.v59i3.3803
BibTeX
@article{Abubakar2026,
author = {Abubakar, Saadia},
title = {Navigating the Thrombus Burden: Is Deferred Stenting the Answer to the No-Reflow Dilemma?},
journal = {Pakistan Heart Journal},
year = {2026},
volume = {59},
number = {3},
pages = {673--675},
doi = {10.47144/phj.v59i3.3803}
}
EUVIMED